R. Galanello

5.8k total citations
128 papers, 4.3k citations indexed

About

R. Galanello is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, R. Galanello has authored 128 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Genetics, 77 papers in Hematology and 31 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in R. Galanello's work include Hemoglobinopathies and Related Disorders (110 papers), Iron Metabolism and Disorders (69 papers) and Blood groups and transfusion (18 papers). R. Galanello is often cited by papers focused on Hemoglobinopathies and Related Disorders (110 papers), Iron Metabolism and Disorders (69 papers) and Blood groups and transfusion (18 papers). R. Galanello collaborates with scholars based in Italy, United States and United Kingdom. R. Galanello's co-authors include Antonio Cao, Susanna Barella, Maria Cristina Rosatelli, N. Giagu, C. Dessì, Liliana Maccioni, Raffaella Origa, Mario Pirastu, E. Paglietti and Gillian Smith and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

R. Galanello

126 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Galanello Italy 37 3.5k 3.0k 987 699 587 128 4.3k
Çiğdem Altay Türkiye 27 1.2k 0.3× 1.1k 0.4× 416 0.4× 734 1.1× 252 0.4× 118 2.4k
Stephan Menzel United Kingdom 30 1.9k 0.5× 1.4k 0.5× 749 0.8× 1.6k 2.3× 338 0.6× 81 3.9k
Yelena Ginzburg United States 22 1.6k 0.5× 1.7k 0.6× 93 0.1× 388 0.6× 524 0.9× 84 2.4k
Nicola Conran Brazil 25 1.5k 0.4× 1.1k 0.4× 190 0.2× 423 0.6× 643 1.1× 105 2.0k
O Platt United States 18 1.3k 0.4× 994 0.3× 274 0.3× 360 0.5× 607 1.0× 21 1.7k
R. M. Bannerman United States 25 488 0.1× 525 0.2× 288 0.3× 314 0.4× 197 0.3× 67 1.6k
Enrico M. Novelli United States 25 1.2k 0.3× 990 0.3× 212 0.2× 470 0.7× 309 0.5× 95 2.1k
Carla Casu United States 20 1.1k 0.3× 1.1k 0.4× 89 0.1× 310 0.4× 440 0.7× 50 1.7k
D. Mark Layton United Kingdom 19 368 0.1× 653 0.2× 227 0.2× 378 0.5× 387 0.7× 62 1.5k
Jaroslav F. Prchal Canada 19 1.5k 0.4× 1.5k 0.5× 76 0.1× 676 1.0× 349 0.6× 39 2.4k

Countries citing papers authored by R. Galanello

Since Specialization
Citations

This map shows the geographic impact of R. Galanello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Galanello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Galanello more than expected).

Fields of papers citing papers by R. Galanello

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Galanello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Galanello. The network helps show where R. Galanello may publish in the future.

Co-authorship network of co-authors of R. Galanello

This figure shows the co-authorship network connecting the top 25 collaborators of R. Galanello. A scholar is included among the top collaborators of R. Galanello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Galanello. R. Galanello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marongiu, Maria Franca, Carla Casu, R. Galanello, et al.. (2013). In vivo activation of the human  -globin gene: the therapeutic potential in  -thalassemic mice. Haematologica. 99(1). 76–84. 20 indexed citations
2.
Danjou, Fabrice, Franco Anni, Lucia Perseu, et al.. (2012). Genetic modifiers of  -thalassemia and clinical severity as assessed by age at first transfusion. Haematologica. 97(7). 989–993. 61 indexed citations
3.
Abbruzzese, Giovanni, Giovanni Cossu, Manuela Balocco, et al.. (2011). A pilot trial of deferiprone for neurodegeneration with brain iron accumulation. Haematologica. 96(11). 1708–1711. 104 indexed citations
4.
Galanello, R., Serena Sanna, Lucia Perseu, et al.. (2009). Amelioration of Sardinian  0 thalassemia by genetic modifiers. Blood. 114(18). 3935–3937. 102 indexed citations
5.
Sollaino, Maria Carla, et al.. (2009). Association of   globin gene quadruplication and heterozygous   thalassemia in patients with thalassemia intermedia. Haematologica. 94(10). 1445–1448. 33 indexed citations
6.
Wood, John C., Raffaella Origa, Annalisa Agus, et al.. (2008). Onset of cardiac iron loading in pediatric patients with thalassemia major. Haematologica. 93(6). 917–920. 81 indexed citations
7.
Angelucci, Emanuele, Giovanni Barosi, Maria Domenica Cappellini, et al.. (2008). Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders. Haematologica. 93(5). 741–752. 149 indexed citations
8.
Origa, Raffaella, Elisa Fiumana, Maria Rita Gamberini, et al.. (2005). Osteoporosis in β‐Thalassemia: Clinical and Genetic Aspects. Annals of the New York Academy of Sciences. 1054(1). 451–456. 38 indexed citations
9.
Galanello, R., et al.. (2001). Cholelithiasis and Gilbert's syndrome in homozygous β‐thalassaemia. British Journal of Haematology. 115(4). 926–928. 59 indexed citations
10.
Galanello, R.. (2001). Iron chelation: New therapies. Seminars in Hematology. 38(1 Suppl 1). 73–76. 17 indexed citations
11.
Melis, MA, M. Cau, Francesco Muntoni, et al.. (1998). Elevation of serum creatine kinase as the only manifestation of an intragenic deletion of the dystrophin gene in three unrelated families. European Journal of Paediatric Neurology. 2(5). 255–261. 56 indexed citations
12.
Paleari, Renata, et al.. (1996). Simultaneous Automated Determination of Glucose 6-Phosphate Dehydrogenase and 6-Phosphogluconate Dehydrogenase Activities in Whole Blood. Clinical Chemistry and Laboratory Medicine (CCLM). 34(5). 431–438. 16 indexed citations
13.
Cazzola, Mario, Piero De Stefano, Luisa Ponchio, et al.. (1995). Relationship between transfusion regimen and suppression of erythropoiesis in β‐thalassaemia major. British Journal of Haematology. 89(3). 473–478. 97 indexed citations
14.
Gasperini, D., Antonio Cao, Susanna Barella, et al.. (1993). Normal individuals with high Hb A2 levels. British Journal of Haematology. 84(1). 166–168. 12 indexed citations
15.
Gasperini, D., et al.. (1990). Molecular pathology of thalassemia intermedia. European Journal of Internal Medicine. 1(3). 227–236. 8 indexed citations
16.
Cao, Antonio, Maria Cristina Rosatelli, R. Galanello, et al.. (1989). The prevention of thalassemia in Sardinia.. PubMed. 36(5). 277–85. 48 indexed citations
17.
Furbetta, M., R. Galanello, Andrea Angius, et al.. (1982). Control of homozygous beta-thalassemia by carrier screening and antenatal diagnosis in Sardinia.. PubMed. 18(7). 303–11. 3 indexed citations
18.
Galanello, R., et al.. (1981). [Our experience in screening and genetic counseling for beta-thalassemia].. PubMed. 72(10). 623–8. 1 indexed citations
19.
Cao, Antonio, M. Furbetta, R. Galanello, et al.. (1981). Prevention of homozygous beta-thalassemia by carrier screening and prenatal diagnosis in Sardinia.. PubMed. 33(4). 592–605. 47 indexed citations
20.
Galanello, R., et al.. (1981). Prospective study of red blood cell indices, hemoglobin A2, and hemoglobin F in infants heterozygous for β-thalassemia. The Journal of Pediatrics. 99(1). 105–108. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026